Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104–111)

Molecular Oncology Group, Biodonostia Research Institute, 20014, San Sebastian, Spain
Charles H. Lawrie
IKERBASQUE, Basque Foundation for Science, Bilbao, Spain
Charles H. Lawrie
Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
Charles H. Lawrie
Sino-Swiss Institute of Advanced Technology (SSIAT), Shanghai University, Shanghai, China
Charles H. Lawrie

Authors

Charles H. Lawrie
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles H. Lawrie.

Ethics declarations

COMPETING INTERESTS

The author declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lawrie, C.H. Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104–111). Br J Cancer 128, 446–447 (2023). https://doi.org/10.1038/s41416-022-02034-8

Download citation

Received: 23 September 2022
Revised: 14 October 2022
Accepted: 17 October 2022
Published: 28 October 2022
Issue Date: 02 February 2023
DOI: https://doi.org/10.1038/s41416-022-02034-8
Springer Nature Limited

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104–111)

Access this article

Author information

Authors and Affiliations